February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTXAccesswire • 2h
Faruqi & Faruqi Reminds Kyverna Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 – KYTXGlobeNewsWire • 2h
Lost Money on Kyverna Therapeutics, Inc. (KYTX)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAccesswire • 3h
Kyverna Therapeutics, Inc. Investors with Large Losses Are Encouraged to Contact Shareholder Rights Law Firm Robbins LLP for Information About the KYTX Class Action LawsuitPRNewsWire • 3h
Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights – KYTXAccesswire • 4h
Kessler Topaz Meltzer & Check, LLP - Class Action Announcement for Kyverna Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Kyverna Therapeutics, Inc.GlobeNewsWire • 5h
KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTXAccesswire • 5h
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Kyverna Therapeutics, Inc. (KYTX) ShareholdersAccesswire • Thursday
ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTXGlobeNewsWire • Thursday
Shareholders of Kyverna Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights - KYTXAccesswire • Thursday
KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud LawsuitPRNewsWire • Thursday
Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law FirmAccesswire • Thursday
February 7, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against KYTXAccesswire • Thursday
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTXAccesswire • Thursday
Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - KYTXAccesswire • Thursday
Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPAccesswire • Thursday
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTXAccesswire • Thursday
KYTX INVESTOR ALERT: Kirby McInerney LLP Notifies Kyverna Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitGlobeNewsWire • Thursday
Class Action Filed Against Kyverna Therapeutics, Inc. (KYTX) Seeking Recovery for Investors - Contact Levi & KorsinskyAccesswire • Thursday
KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Kyverna Therapeutics, Inc. to Contact the Firm Today!Accesswire • Thursday
KYTX Stockholders Have Opportunity to Lead Kyverna Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!Accesswire • Thursday
Contact The Gross Law Firm by February 7, 2025 Deadline to Join Class Action Against Kyverna Therapeutics, Inc.(KYTX)PRNewsWire • Thursday
Kyverna Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 7, 2025 to Discuss Your Rights - KYTXAccesswire • Thursday
Lost Money on Kyverna Therapeutics, Inc. (KYTX)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyAccesswire • Tuesday
KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • Tuesday
